Replies to post #428424 on NorthWest Biotherapeutics Inc (NWBO)

[FeMike]

Yes, I know what this means.

I am aware that they can now produce DCVax for treatment.

I'm not denying any of this.

[Fireman02360]

MI,

How many patients are available to treat in the specials program? And how much does treatment cost per-patient? If you could provide some numbers and added color to the situation (ramifications of the MHRA approval) would be greatly appreciated.

Also, I am assuming this will lead to revenue before the drug is officially approved? I know in other Countrys, Australia for instance, patients can stay on a Open Label Extension (OLE) but the Company absorbs the cost of the drug. Anavex Life Sciences ($AVXL) has been doing this with the Alzheimer's, Parkinson's and Rett trial in Australia and Spain. This "specials" program in the UK is different?

-Fireman